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Human papillomavirus induced (HPV+) oropharyngeal cancer is quickly
rising in the United States, accounting for as much as 70% of
oropharyngeal cancers1.
Understanding the genetic determinants in the tumor microenvironment
(TME) is important for rational designing of therapeutic strategies.
The mouse tonsil derived epithelial tumor cell line expressing HPV-16 E6
and E7 genes is well-established as a surrogate preclinical oral HPV
cancer model.
In a recent study using this model, it was observed that mEER tumors
implanted in the orthotopic site (tongue) were responsive to anti-PD1
immunotherapy, while those implanted in the flank (non-orthotopic) were
resistant to treatment4.

●

tongue and flank tumor accounts for positive and negative loadings in
the first principal component (PC1) and that (B) the first principal
component accounts for 53.3% of the variability. Additionally, the second
Flank sample accounts for majority loading of PC2 which accounts for
19.9% of variability. Hence, this sample is removed as an outlier.

Biological Pathway Analysis via IPA
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The set of significant differentially expressed genes were further
analyzed using Ingenuity Pathway Analysis (IPA) to obtain insights on
potential pathways associated with treatment responsiveness.
The p-value for canonical pathways were calculated using Fisher’s Ttest and the cutoff threshold was set to -log(p-value) ≥ 1.5.

Figure 3. Statistically significant canonical pathways identified by
IPA. Higher z-score corresponds to pathways that are predicted to
be activated, while lower z-score correspond to inhibited pathways.
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Results
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Upstream Analysis highlights two networks related to cytokine
expression that may impact immunotherapy response (Fig. 4).
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Identification of Differential Gene Expression
●

Upon further examination of natural killer
activator and inhibitory molecules and NKDC,
we identified overexpression in CD96 and
PDCD1 (PD1) in mEER tongue tumors, as
potential targets for immunotherapy using
anti-CD96 and anti-PD1 checkpoint
antibodies (Fig. 2, Table 2).
Importantly, these gene expression analyses
data are validated in experiments where
tongue implanted tumors showed better
response to anti-CD96 (unpublished) and
anti-PD1 immunotherapies4.

Table 2.

Conclusion

Methods (Continued)

RNA was extracted from preclinical mEER tumor samples, alongside with
immune cell infiltrates, for both the tongue and flank models.
RNA data was then subjected to quality control testing, leaving 3 samples
of the flank tumor and 2 samples of tongue tumor for further sequencing.

DESeq2 and Q-value were determined with the R software and employed
to evaluate differential gene expression between the groups.
The gene expression data is calculated based on the ratio of CPM
(counts per million) values, normalized between samples, and principal
component analysis (PCA) was performed to ensure that tumor location
difference accounts for the majority of variance between gene expression
data (Fig. 1).
A sample of the flank-implanted mEER tumor group is removed due to
PCA results highlighting it as an outlier relative to the remaining samples.
Log fold change values of gene expression were calculated by taking the
difference between the average expression of each individual gene from
the two groups using the Flank group as baseline, and only genes with
an absolute value of log2 ratio ≥ 2 were used for ingenuity’s pathway
analysis.

●

●

Differences in the expression of genes important for cytotoxic function
of innate and adaptive antitumor effector cells (CD8 T cells and NK
cells) are associated with response to immune checkpoint therapy
There is higher expression of cytokines, signaling molecules that
mediate and regulate immunity, in the sample of mEER tumors
implanted in tongue.

Identification of Differential Gene Expression
●

Natural Killer Activators and Inhibitors

28 statistically significant canonical pathways were identified (Fig.3).
Of which, it consists of activated immunological pathways such as
interferon signaling and crosstalk between dendritic cells and
natural kills cells.

Figure 1. Principle Component Analysis results displaying that (A)

RNA Extraction and Sequencing
●

Biological Pathway Analysis via IPA
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Hypothesis
●

Results (Continued)

●

485 differentially expressed genes altered by >2 log2 fold change in
tongue-implanted mEER tumors relative to flank tumors were
identified.
We observe significant upregulation in the expression of immune
function related genes encoding such as IFNγ, Cxcl9, Chil1, and
Gzmb in mEER oral tumors (Fig. 2).

●

B

Cytokines and chemokines crucial to immune response is observed
to be overexpressed In the tongue implanted mEER tumor samples,
which are molecular signatures indicative of an immunologically
‘hot’ tumor relative to the flank1.
The lack of significant differential expression for most natural killer
cell activators and inhibitors such as TIGIT, Lag3, and Tlr3
alongside the abundance of cytokines overexpression and evidence
of activated interferon signaling in the tongue tumor suggests that
while the immune system may recognize the presence of the tongue
tumor, there is blockade in effective attack against the tumor itself
whereas the immune system may not be recognizing the tumor in
the flank implanted tumor sample5.
The overexpression of CD96 and PD1, despite their role as natural
killer cell inhibitors, in the tongue implanted mEER tumor suggests
that immunotherapy efficacy is higher for the tongue implanted
tumors due to an abundance of checkpoint molecules identified for
targeting.
Further studies should be conducted to determine the exact effects
of the overexpressed chemokines in the tongue implanted model.

Figure 4. Mechanistic networks of (A) IFNγ and (B) IFN-β1, two
upstream regulators crucial for anti-tumor immune response.
●

Figure 2. Heatmaps of normalized gene expression values (in CPM)
of (A) the top differentially expressed cytokines and chemokines6
and (B) NK cell relevant activators, inhibitors2,3,5.

●

The downstream function analysis
predicted an increase in natural
killer cell movement (z-score of
2.380, overlap p-value of 1.03E03) activation of antigen
presenting cells (z-score of 1.738,
overlap p-value of 3.80E-04), and
cytotoxic T-cell activity.
These activities are consistent
with upregulation of various gene
encodes such as IFNγ, Cxcl9,
Ccl2, etc. (Shown in Table 1)
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